Global Flexible Endoscope Market 2026 – 2035
Report Code
HF1002
Published
February 9, 2026
Pages
220+
Format
PDF, Excel
Revenue, 2026
13.5 Billion
Forecast, 2035
22.7 Billion
CAGR, 2026-2035
6%
Report Coverage
Global
Market Overview
The market size of the global flexible endoscope will be estimated at USD 12.7 billion in 2025 and is expected to grow between USD 13.5 billion in 2026 and about USD 22.7 billion by 2035 with a current CAGR of 6% during the period of 2026 to 2035.
The flexible endoscopic tools market is primarily driven by the growing global prevalence of gastrointestinal and respiratory disorders, thus leading to the adoption of more endoscopic diagnostic and therapeutic methods like colonoscopy, gastroscopy, and bronchoscopy. One of the main reasons for the rise in the number of procedures and the never-ending demand of flexible endoscopes in hospitals and outpatient clinics is the increasing application of cancer screening programs, particularly for colorectal cancer.
Market Highlight
North America had a market share of 40% market leader in the flexible endoscope market in 2025.
It is projected to have the highest growth rate across Asia Pacific in the year 2026-2035.
By product, the gastrointestinal endoscopes segment dominates the market over 55% revenue share in 2025.
By end use, the hospital held the largest market share of 65% in 2025.
Significant Growth Factors
The flexible endoscope market trends present significant growth opportunities due to several factors:
Growing innovative product launch: The growing innovative product launch by the key market players are expected to offer a potential opportunity to the market growth. For instance, in May 2025, FUJIFILM Healthcare Europe has declared the investment of the new therapeutic gastroscopes ELUXEO® EG-840T and the specially designed narrow EG-840TP endoscope for advanced treatment in Europe. The ELUXEO® 8000 system, which has made remarkable progress, is the first one and the next one to be released to all the innovations under the ‘WELCOME, FUTURE’ initiative. With the new gastroscopes, FUJIFILM has not only focused on observation and diagnosis but also on advanced endoscopic treatment. In the treatment of early-stage cancers of the gastrointestinal tract, such as the oesophagus and stomach, therapeutic procedures with low physical burden to the patient, such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), have become increasingly popular in recent times. These endoscopic procedures require advanced techniques that demand enhanced endoscope operability and approachability included in their leading new ELUXEO® endoscopes.
Rising Global Burden of Gastrointestinal and Pulmonary Diseases: The rise in global health issues related to the gastrointestinal and pulmonary systems indicates that there is a continuous trend of increasing prevalence of these disorders in different parts of the world, and, mainly, the aging population is the main reason for this. In addition to aging populations, other causes contributing to the increasing incidence of these diseases are changes in lifestyles, environmental pollution, smoking, poor nutrition, obesity, and the higher incidence of chronic conditions. The digestive system is afflicted more and more by diseases such as gastroesophageal reflux disease (GERD), peptic ulcers, inflammatory bowel disease, colorectal cancer, and gastrointestinal bleeding; on the other hand, the respiratory system is suffering from conditions like chronic obstructive pulmonary disease (COPD), lung infections, airway tumors, and asthma which are also on the rise. The growing burden of these diseases translates into a greater need for diagnostic and therapeutic procedures, particularly endoscopy and bronchoscopy, since clinical priorities are early diagnosis, disease monitoring, and minimally invasive treatment. Therefore, healthcare practitioners have come to depend more and more on flexible endoscopes for accurate viewing, taking tissue samples, and carrying out interventions which has made the increasing incidence of gastrointestinal and pulmonary diseases one of the primary factors driving demand in the flexible endoscope market. For instance, according to the World Gastroenterology Organisation (WGO), Gastrointestinal (GI) cancers represent around one-fourth of all cancer cases and one-third of all cancer deaths worldwide. The rates of incidence and mortality show large differences among different parts of the world to a great extent.
What are the Major Advances Changing the Flexible Endoscope Market Today
Artificial Intelligence (AI)-Powered Imaging: Imaging powered by Artificial Intelligence (AI) is a radical shift in the flexible endoscope market since it actually transforms the way diseases go through the steps of detection, interpretation and being referred for treatment in the course of endoscopic procedures. AI algorithms that are part of the endoscopy system scrutinize the live video feed in real time for the purpose of spotting anomalies like polyps, lesions, bleeding points, or even cancers at their initial stage, which are subtle or easily overlooked by the human eye. This procedure leads to a remarkable detection rate increase—especially in cases of colorectal cancer and pre-cancerous polyps—along with decreased operator reliance and less variation among the doctors. AI also plays a role in computer-aided diagnosis (CAD) by giving the character of the lesion (size, shape, surface pattern) and helping to tell the difference between cancerous and non-cancerous tissue, thus leading to quicker and more confident clinical decision-making. Also, AI-powered imaging is a factor that improves the efficiency of the workflow by cutting procedure times, eliminating the need for re-examinations, and helping to train the younger generation of endoscopists. In the new era of healthcare systems that give priority to the early diagnosis, and quality metrics, and better patient outcomes, the AI-enabled flexible endoscopes are no longer just a differentiator but also a strong driver of technology upgrades and market-vise growth.
Advanced Tissue Imaging (Optical Biopsy): The leading-edge tissue imaging, known sometimes as optical biopsy, is revolutionizing the flexible endoscope industry by allowing endoscopic procedures to have non-invasive, real-time, microscopic visualization of the tissue without the need for physical biopsy removal. Through techniques like confocal laser endomicroscopy (CLE), optical coherence tomography (OCT), and advanced fluorescence imaging, optical biopsy enables doctors to view the cellular and subcellular structures in the body. Such a capability helps in the immediate classification of tissues according to their nature which in return supports the early detection of cancer and the correct targeting of the therapeutic interventions. One of the biggest benefits of optical biopsy is that it reduces the need for traditional biopsy and histopathology, leading to quicker diagnosis, lower procedural costs, and less risk and discomfort for patients. Sophisticated tissue imaging is not only a breakthrough in technology but also a huge step forward in winning the flexible endoscope market through innovation and premium adoption, as the healthcare systems are putting more emphasis on precision medicine, quicker clinical decisions, and less invasive diagnostics.
Category Wise Insights
By Product
Why Gastrointestinal Endoscopes Lead the Market?
The gastrointestinal endoscopes segment dominates the market over 55% revenue share in 2025. The growing prevalence of gastrointestinal disorders like colorectal cancer, inflammatory bowel diseases, and other chronic conditions that require regular diagnosis and thus increased demand for diagnostic procedures. For example, the American Cancer Society states that the year 2023 will see around 26,500 new cases of stomach cancer diagnosed in the United States, thereby underscoring the urgent need for and the role of endoscopes as one of the effective diagnostic methods. In addition, the awareness of flexible gastroscopes' advantages is increasing, and researchers are likely to be among the factors as their adoption will support considerable market growth.
The laparoscopes segment is expected to grow at the highest CAGR over the projected period. The increase in conditions that demand laparoscopic procedures, like obesity and a range of gastrointestinal disorders, has made the need for powerful diagnostic and surgical tools even more pressing. In addition, the hospitals and clinics healthcare providers have been attracting the machines due to the gradually increasing investments and technology that have already been improved in the area of imaging and flexible laparoscopes. Still, the cost aspect is very significant; operations employing laparoscopes are much cheaper than those that use reusable instruments because of the costs involved in sterilization, and there is always a risk of infection leading to complications. For example, in April 2023, the medical device company Xenocor was able to secure USD 10 million in Series A funding, which was led by GenHenn Venture Fund I and also included other investors such as Patel Family Investment, Barvest Ventures, Inc., and Baranco Investments, Inc.
By End Use
Why hospitals Dominates the Flexible Endoscope Market?
The hospital held the largest market share of 65% in 2025. The hospital industry's earnings from flexible endoscopes have been on a very strong upward trend for the past few years since these devices are very useful in diagnosing and treating many different conditions, both chronic and acute. Gastrointestinal, pulmonary, and urological diseases are the most common types of healthcare issues that hospitals encounter all over the world. The hospitals are conducting more endoscopic procedures such as colonoscopy, gastroscopy, and bronchoscopy because of the rising disease incidence and the greater focus on early detection and preventive care, which in turn is increasing the demand for flexible endoscopes and related services directly.
The outpatient facilities segment is expected to grow at the highest rate over the projected period. The rising prevalence of outpatient centers that conduct endoscopic operations is the vital element encouraging the segment demand. Additionally, some advantages like easy access to outpatient facilities and lower-priced services are helping the market to grow. Besides, the government's support for healthcare infrastructure development is anticipated to contribute to the segment's growth throughout the forecast period.
Report Scope
Feature of the Report | Details |
|---|---|
Market Size in 2026 | USD 13.5 billion |
Projected Market Size in 2035 | USD 22.7 billion |
Market Size in 2025 | USD 12.7 billion |
CAGR Growth Rate | 6% CAGR |
Base Year | 2025 |
Forecast Period | 2026-2035 |
Key Segment | By Product, End Use and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Regional Analysis
How Big is the North America Flexible Endoscope Market Size?
Its market size, in terms of North America flexible endoscope, is projected to be USD 5.1 billion in 2025 with a growth of about USD 8.6 billion in 2035 with a CAGR of 5.4% between 2026 and 2035.
Why did North America Dominate the Flexible Endoscope Market in 2025?
In 2025, North America will dominate the global market with an estimated market share of 40%. The regional growth is owing to the presence of major players and increasing product launch by them. For instance, in September 2025, Olympus Corporation of the Americas, a worldwide medical technology firm dedicated to improving the health, safety and satisfaction of human beings, has made public the VISERA S OTV-S500 imaging platform, that combines state-of-the-art diagnostics for ENT and urology and gives an option of office and outpatient use, thus very easy to use, each patient will feel very comfortable and relaxed during the procedure.
U.S. Flexible Endoscope Market Trends
The US is expected to lead the flexible endoscope market over the analysis period. A considerable volume of diagnostics and therapies, particularly gastrointestinal endoscopic procedures (including colonoscopies and gastroscopies), always keep the market for flexible endoscopes very strong as medical providers want to detect colorectal cancer and bowel inflammation early. The healthcare facilities in the U.S. are buying state-of-the-art endoscopy machines for these tasks, which will consequently bring the hospitals both capital and service revenues.
Why is Asia Pacific Experiencing the Fastest Growth in the Flexible Endoscope Market?
The Asia Pacific region is expected to grow at the highest CAGR during the projected period. The main reason for this growth is the high prevalence of the diseases targeted by the therapies, and the large population of patients is likely to help the region's growth. The healthcare infrastructure is getting better, and companies are putting more money into the region because of the great demand for medical devices, which has in turn increased the region's growth to some extent.
India Flexible Endoscope Market Trends
The Indian market has an extremely fast-growing market because of the country's growing product developments and innovations. For example, in the month of July in the year 2024, FUJIFILM India increased its healthcare range by setting up a new endoscopy center in the city of Mumbai.
Why is Europe is growing at a significant rate in the Flexible Endoscope Market?
The European market is large and established. In Europe, the increased preference to reduce the risk of infection and at the same time provide better clinical outcomes has led to the wider use of flexible endoscopes and their related accessories. On top of this, the rise in functional GI disorders and chronic diseases such as diabetes, cancer, and heart problems has led to an increased diagnosis rate over the years, which is expected to drive the market growth further. For example, as per an article released by the European Commission in January 2024, in 29 European countries it was estimated that 23.7 million people would be diagnosed with cancer at some point in their lives.
UK Flexible Endoscope Market Trends
In 2025, the UK Flexible Endoscope industry took a considerable market share. In the country, the factors such as the high cancer and chronic diseases prevalence rate together with the aged population growth are likely to propel the market progress.
Why is the Middle East & Africa Region is growing rapidly in the Flexible Endoscope?
The MEA region has a steady growth rate over the projected period. There are a number of significant factors responsible for the MEA growth. The healthcare infrastructure and investment improvements made in the United Arab Emirates, Saudi Arabia, and other major markets, along with South Africa, are all building up the capacity for high-tech diagnostics and surgical treatments that are less invasive.
UAE Flexible Endoscope Market Trends
UAE is growing rapidly over the projected period. The growing investment in healthcare infrastructure and increasing preference of non-invasive surgical procedures.
Top Players in the Flexible Endoscope Market and Their Offerings
Olympus Corporation
Cook Medical Inc.
Becton Dickinson and Company
Boston Scientific Corporation
Cantel Medical Corporation
Conmed Corporation
B. Braun SE
EndoMed Systems GmbH
Firefly Global
Fujifilm Holdings Corporation
H.W.Andersen Products Ltd.
Hoya Corporation
Intuitive Surgical Inc.
Karl Storz SE & Co. KG
Machida Endoscope Co. Ltd
Ambu A/S
Others
Key Developments
Flexible endoscope market has experienced considerable changes in the last two years as the market players are trying to diversify their technological aspects and develop product portfolio using strategic approaches.
In October 2025: The Olympus Corporation (Olympus), a world-wide MedTech enterprise dedicated to improve health, safety and quality of human life, has declared the introduction of a fine needle biopsy device called SecureFlex that is solely for one-time use. (Source: https://www.olympus-global.com/news/2025/nr02913.html )
These strategic measures have enabled the companies to reinforce their competitive positions, increase the product line, boost their technological competencies and also seize growth opportunities in the fast-growing Flexible Endoscope market.
The Flexible Endoscope Market is segmented as follows:
By Product
Bronchoscopes
Laparoscopes
Otoscopes
Laryngoscopes
Cystoscopes
Ureteroscopes
Arthroscopes
Nasopharyngoscopes
Neuroendoscopes
Rhinoscopes
Gastrointestinal Endoscopes
Hysteroscopes
Gynecology Endoscopes
By End Use
Hospitals
Outpatient Facilities
Regional Coverage:
North America
U.S.
Canada
Mexico
Rest of North America
Europe
Germany
France
U.K.
Russia
Italy
Spain
Netherlands
Rest of Europe
Asia Pacific
China
Japan
India
New Zealand
Australia
South Korea
Taiwan
Rest of Asia Pacific
The Middle East & Africa
Saudi Arabia
UAE
Egypt
Kuwait
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Competitive Landscape
The market is characterized by intense competition among established players and emerging companies. Strategic partnerships, mergers and acquisitions, and product innovation are key strategies employed by market participants.
Key Market Players
Olympus Corporation
Market Share
XX
Cook Medical Inc.
Market Share
XX
Becton Dickinson and Company
Market Share
XX
Boston Scientific Corporation
Market Share
XX
Cantel Medical Corporation
Market Share
XX
Conmed Corporation
Market Share
XX
B. Braun SE
Market Share
XX
EndoMed Systems GmbH
Market Share
XX
Firefly Global
Market Share
XX
Fujifilm Holdings Corporation
Market Share
XX
H.W.Andersen Products Ltd.
Market Share
XX
Hoya Corporation
Market Share
XX
Intuitive Surgical Inc.
Market Share
XX
Karl Storz SE & Co. KG
Market Share
XX
Machida Endoscope Co. Ltd
Market Share
XX
Ambu A/S
Market Share
XX
Others
Market Share
XX
Meet the Team
This report was prepared by our expert analysts with deep industry knowledge and research experience.
